Federal grants to Senex Biotechnology Inc
Senex Biotechnology Inc in Columbia, South Carolina received $2.7 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cancer Treatment Research, with $1.6 million. In fiscal 2025 it was awarded $400,000.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.7 million
- Awards4
- Awarded in FY 2025$400,000
- Largest award$1.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $846,340 |
| FY 2022 | 2 | $1.4 million |
| FY 2023 | 0 | $0 |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $400,000 |
Programs that fund Senex Biotechnology Inc
| Program | Awards | Amount |
|---|---|---|
| Cancer Treatment Research | 3 | $1.6 million |
| Military Medical Research and Development | 1 | $1.1 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $1.6 million |
| Department of Defense | 1 | $1.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Developing mediator kinase inhibitor for castration-refractory prostate cancer | Military Medical Research and Development | March 21, 2022 | $1.1 million |
| CDK8/19 inhibitors for therapy of advanced prostate cancer | Cancer Treatment Research | May 28, 2021 | $846,340 |
| Preventing in vivo resistance to PI3K/akt/mtor inhibitors through mediator kinase inhibition - dysregulation of the PI3K/akt/mtor pathway is one of the most common genetic alterations in cancer, found in more than one third of all solid tumors. Inhibitors of the key components of this pathway (mtor, | Cancer Treatment Research | September 12, 2022 | $400,000 |
| Nanoparticle formulation of mediator kinase inhibitor for the treatment of peritoneal ovarian cancer - metastatic ovarian cancers (OC), the second most common gynecological malignancy, is a lethal disease, the treatment of which still relies primarily on conventional cytotoxic drugs. Metastatic oc i | Cancer Treatment Research | December 13, 2024 | $400,000 |
Questions people ask
How much federal grant money does Senex Biotechnology Inc get?
$2.7 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Senex Biotechnology Inc the most?
The Department of Health and Human Services, with $1.6 million in 3 awards. The Department of Defense follow.
What is Senex Biotechnology Inc's largest federal grant?
$1.1 million under Military Medical Research and Development, with its first action in the period on March 21, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Senex Biotechnology Inc?
Its largest are Cancer Treatment Research and Military Medical Research and Development.
Other grant recipients in Columbia
- Department of Health Human Services
- South Carolina Department of Education
- South Carolina Department of Transportation
- Social Services South Carolina Department
- South Carolina Department of Public Health
- South Carolina Department of Social Services
- Adjutant General South Carolina
- University of South Carolina
Largest federal grant recipients in South Carolina · Federal grants in South Carolina